β-lactamases:: which ones are clinically important?

被引:52
作者
Rice, LB
Bonomo, RA
机构
[1] VA Med Ctr, Med Serv 111W, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA
关键词
D O I
10.1054/drup.2000.0144
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The introduction of a large array of beta-lactam antibiotics has spawned the emergence of an even larger variety of beta-lactamases designed to confer resistance to these agents. beta-lactamases are produced by both gram-positive and gram-negative bacteria, but their clinical importance is far greater among the gram-negatives. The virtual explosion in our knowledge about the variety of these enzymes can often create confusion and frustration among those not well versed in the field. In this paper, we attempt to focus the discussion of beta-lactamases on those enzymes that are of the greatest clinical importance, the Ambler Class A and C enzymes. We also discuss the growing importance of the Ambler Class B metallo beta-lactamases, which hydrolyze carbapenems and are increasing in prevalence in areas of significant carbapenem usage. (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:178 / 189
页数:12
相关论文
共 91 条
  • [31] Hanson ND, 1999, CURR PHARM DESIGN, V5, P881
  • [32] REVERSAL OF CLAVULANATE RESISTANCE CONFERRED BY A SER-244 MUTANT OF TEM-1 BETA-LACTAMASE AS A RESULT OF A 2ND MUTATION (ARG TO SER AT POSITION-164) THAT ENHANCES ACTIVITY AGAINST CEFTAZIDIME
    IMTIAZ, U
    MANAVATHU, EK
    MOBASHERY, S
    LERNER, SA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (05) : 1134 - 1139
  • [33] Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria
    Jacobs, C
    Frere, JM
    Normark, S
    [J]. CELL, 1997, 88 (06) : 823 - 832
  • [34] AMPD, ESSENTIAL FOR BOTH BETA-LACTAMASE REGULATION AND CELL-WALL RECYCLING, IS A NOVEL CYTOSOLIC N-ACETYLMURAMYL-L-ALANINE AMIDASE
    JACOBS, C
    JORIS, B
    JAMIN, M
    KLARSOV, K
    VANBEEUMEN, J
    MENGINLECREULX, D
    VANHEIJENOORT, J
    PARK, JT
    NORMARK, S
    FRERE, JM
    [J]. MOLECULAR MICROBIOLOGY, 1995, 15 (03) : 553 - 559
  • [35] BACTERIAL-CELL WALL RECYCLING PROVIDES CYTOSOLIC MUROPEPTIDES AS EFFECTORS FOR BETA-LACTAMASE INDUCTION
    JACOBS, C
    HUANG, LJ
    BARTOWSKY, E
    NORMARK, S
    PARK, JT
    [J]. EMBO JOURNAL, 1994, 13 (19) : 4684 - 4694
  • [36] Sequence of the MIR-1 β-lactamase gene
    Jacoby, GA
    Tran, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) : 1759 - 1760
  • [37] MORE EXTENDED-SPECTRUM BETA-LACTAMASES
    JACOBY, GA
    MEDEIROS, AA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) : 1697 - 1704
  • [38] Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections
    Kernodle, DS
    Classen, DC
    Stratton, CW
    Kaiser, AB
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (01) : 219 - 222
  • [39] COMPARATIVE PROPHYLACTIC EFFICACY OF CEFAZOLIN AND VANCOMYCIN IN A GUINEA-PIG MODEL OF STAPHYLOCOCCUS-AUREUS WOUND-INFECTION
    KERNODLE, DS
    KAISER, AB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (01) : 152 - 157
  • [40] Structure of the SHV-1 β-lactamase
    Kuzin, AP
    Nukaga, M
    Nukaga, Y
    Hujer, AM
    Bonomo, RA
    Knox, JR
    [J]. BIOCHEMISTRY, 1999, 38 (18) : 5720 - 5727